Unknown

Dataset Information

Predictors of clinically significant prostate cancer in biopsy-naive and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator.


ABSTRACT:

Purpose

A pre-biopsy decision aid is needed to counsel men with a clinical suspicion for clinically significant prostate cancer (csPCa), despite normal prostate magnetic resonance imaging (MRI).

Methods

A risk calculator (RC) for csPCa (International Society of Urological Pathology grade group (ISUP) ⩾ 2) presence in men with a negative-MRI (Prostate Imaging-Reporting and Data System (PI-RADS) ⩽ 2) was developed, and its performance was compared with RCs of the European Randomized Study of Screening for Prostate Cancer (ERSPC), Prostate Biopsy Collaborative Group (PBCG), and Prospective Loyola University mpMRI (PLUM). All biopsy-naïve and prior negative biopsy men with a negative-MRI followed by systematic prostate biopsy were included from October 2015 to September 2021. Th

SUBMITTER: van Riel LAMJG 

PROVIDER: S-EPMC8958520 | biostudies-literature | 2022 Jan-Dec

REPOSITORIES: biostudies-literature